What do you anticipate to be the most significant development in the near future for patients with multiple myeloma?

Professor Graham Jackson discusses the importance of utilising current tools more effectively to improve early diagnosis and risk assessment in multiple myeloma as well as the future potential of novel therapies and management techniques.

The views expressed in this video are those of the speaker.

To view this expert’s biography please visit the Myeloma Hub Faculty page.

UK/NP/1806/0035(1)l - November 2018

You are now leaving the Myeloma Hub

This link opens another website that is not under the review or control of Takeda UK Ltd and, as such, the company does not endorse the content, its accuracy, or any practices or standards contained within it. Please confirm you wish to continue.